Possible sporadic rapid-onset dystonia-parkinsonism

Movement Disorders

Volumn 17, Issue 3, 2002, Pages 608-609

  Linazasoro, Gurutz ^a   Indakoetxea, Begoña ^b   Ruiz, Javier ^c   Van Blercom, Nadege ^a   Lasa, Asier ^a  

^a Centro Neurologia Neurocirugia   (Spain)

^b Servicio de Neurologia   (Spain)

^c HOSPITAL DE MENDARO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BACLOFEN; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; HOMOVANILLIC ACID; LEVODOPA; PERGOLIDE; PIMOZIDE; TETRABENAZINE; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID LEVEL; CHROMOSOME 19Q; CHROMOSOME MARKER; CLINICAL FEATURE; DISEASE COURSE; DOPAMINERGIC TRANSMISSION; DYSARTHRIA; DYSPHAGIA; DYSTONIA; FAMILY HISTORY; FEMALE; GENETIC DISORDER; HUMAN; PARKINSONISM; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYMPTOMATOLOGY; X CHROMOSOME LINKAGE;

ADULT; DOPAMINE; DYSTONIC DISORDERS; FEMALE; HOMOVANILLIC ACID; HUMANS; PARKINSON DISEASE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036590142     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10103     Document Type: Article

References (12)

1. Dobyns WB, Ozelius LJ, Kramer PL, Brashear A, Farlow MR, Perry TR, Walsh LE, Kasarskis EJ, Butler IJ, Breakefield XO. Rapid-onset dystonia-parkinsonism. Neurology 1993;43:2596-2602.
2. Brashear A, Farlow MR, Butler IJ, Kasarskis EJ, Dobyns WB. Variable phenotype of rapid-onset dystonia-parkinsonism. Mov Disord 1996;11:151-156.
3. Brashear A, DeLeon D, Bressman SB, Thyagarajan D, Farlow MR, Dobyns WB. Rapid-onset dystonia-parkinsonism in a second family. Neurology 1997;48:1066-1069.
4. Webb DW, Broderick A, Brashear A, Dobyns WB. Rapid-onset dystonia-parkinsonism in a 14 year old girl. Europ J Paediatr Neurol 1999;3:171-173.
5. Pittock SJ, Joyce C, O'Keane V, Hugle B, Hardiman MO, Brett F, Green AJ, Barton DE, King MD, Webb DW. Rapid-onset dyatonia-parkinsonisma clinical and genetic analysis of a new kindred. Neurology 2000;55:991-995.
6. Brashear A, Butler IJ, Hyland K, Farlow MR, Dobyns WB. Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism. Ann Neurol 1998;43:521-526.
7. Brashear A, Mulholland GK, Zheng QH, Farlow MR, Siemers ER, Hutchins GD. PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP). Mov Disord 1999;14:132-137.
8. Kramer PL, Mineta M, Klein C, Schilling K, de Leon D, Farlow MR, Breakefield XO, Bressman SB, Dobyns WB, Ozelius LJ, Brashear A. Rapid-onset dystonia-parkinsonism: linkage to chromosome 19q13. Ann Neurol 1999;46:176-182.
9. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystoniaa. Neurology 1985;35:73-77.
10. Lang AE, Fahn S. Assessment of Parkinson's disease. In: Munsat TL, editor. Quantification of neurologic deficit. Boston: Butterworth-Heinemann; 1989. p 285-309.
11. Fahn S, Marsden CD, Calne DB. Classification and investigation of dystonia. In: Marsden CD, Fahn S, editors. Movement disorders 2nd ed.. London: Butterworth-Heinemann; 1987. p 332-358.
12. Hyland K, Arnold LA, Trugman JM. Defects of biopterin metabolism and biogenic amine biosyntheses: clinical, diagnostic and therapeutic aspects. Adv Neurol 1998;78:301-308.